These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 398524

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Caclium, phosphorus, and bone in renal disease and transplantation.
    Bricker NS, Slatopolsky E, Reiss E, Avioli LV.
    Arch Intern Med; 1969 May; 123(5):543-53. PubMed ID: 4888973
    [No Abstract] [Full Text] [Related]

  • 3. [Disorders of calcium metabolism in kidney failure].
    Ritz E, Krempien B, Andrassy K.
    Med Klin; 1972 Sep 08; 67(36):1129-32. PubMed ID: 4561354
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Vitamin D: synthesis, metabolism, regulation, and an assessment of its deficiency in patients with chronic renal disease].
    Spustová V, Dzúrik R.
    Vnitr Lek; 2004 Jul 08; 50(7):537-43. PubMed ID: 15323262
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 08; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Current problems of azotemic bone diseases].
    Schaefer K, Opitz A.
    Dtsch Med Wochenschr; 1970 Jan 09; 95(2):84-8. PubMed ID: 4902985
    [No Abstract] [Full Text] [Related]

  • 13. Bone disease and chronic renal failure.
    Bourke E.
    Ir J Med Sci; 1974 Jul 09; 0(0):suppl:72-4. PubMed ID: 4604173
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Azotemic renal osteodystrophy.
    Baker J, Anderson KC, Ross G.
    Mo Med; 1966 Oct 09; 63(10):807-10. PubMed ID: 5976677
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J, Liu S, Quarles LD.
    Semin Dial; 2007 Oct 09; 20(4):302-8. PubMed ID: 17635819
    [Abstract] [Full Text] [Related]

  • 18. Treatment of renal osteodystrophy with 25-hydroxycholecalciferol.
    DeLuca HF, Avioli LV.
    Arch Intern Med; 1970 Nov 09; 126(5):896-9. PubMed ID: 4319937
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.